March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said
on Wednesday a combination of its drugs, Opdivo and Yervoy, met
the main goal of a late-stage study evaluating it as a
first-line treatment for a type of liver cancer.
(Reporting by Puyaan Singh)